MedPath

Non -Interventional Study-Palliative Therapy of Multiple Myeloma With a Combination of Lenalidomide and Dexamethasone

Completed
Conditions
Multiple Myeloma
Registration Number
NCT00911105
Lead Sponsor
iOMEDICO AG
Brief Summary

Purpose of this non-interventional study is the documentation of efficacy and safety data of multiple myeloma therapy with a combined treatment of Lenalidomide and Dexamethasone in daily routine practice.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
101
Inclusion Criteria
  • Patients with multiple myeloma with at least one previous therapy.
  • 18 years or older
  • Signed, written informed consent
Exclusion Criteria
  • Pregnancy or nursing
  • All other exclusion criteria listed in SmPC (summary of product characteristics)

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Time to progression (TTP)maximum 3 years per Patient
Secondary Outcome Measures
NameTimeMethod
Kidney Functionmaximum 3 years per Patient
Thrombosis Prophylaxismaximum 3 years per Patient
Overall Response Ratemaximum 3 years per Patient
Time to Treatment Discontinuation (TTD)maximum 3 years per Patient
Overall Survival (OS)maximum 3 years per Patient
Safety Profilemaximum 3 years per Patient
Dosage of Lenalidomide and Dexamethasonemaximum 3 years per Patient
Neutropenia / Infection (Concomitant Medication)maximum 3 years per Patient

Trial Locations

Locations (17)

Onkologische Schwerpunktpraxis

🇩🇪

Berlin, Germany

Onkologisches Versorgungszentrum Friedrichshain

🇩🇪

Berlin, Germany

Onkologische Praxis

🇩🇪

Berlin, Germany

Onkologische Gemeinschaftspraxis

🇩🇪

Wuerselen, Germany

Praxis für Innere Medizin

🇩🇪

Germering, Germany

MedResearch - Medizinisches Studien- und Dokumentationszentrum Leipziger Land

🇩🇪

Groitzsch, Germany

Internistische Gemeinschaftspraxis

🇩🇪

Guestrow, Germany

Praxis für Innere Medizin, Haematologie und Internistische Onkologie

🇩🇪

Hamburg, Germany

Tumorpraxis Heidenheim

🇩🇪

Heidenheim, Germany

Onkol. Gem.praxis Dr. M. Neise & Dr. A. Lollert

🇩🇪

Krefeld, Germany

Scroll for more (7 remaining)
Onkologische Schwerpunktpraxis
🇩🇪Berlin, Germany

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.